+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market 2021-2028

  • PDF Icon

    Report

  • 170 Pages
  • August 2021
  • Region: Asia Pacific
  • Triton Market Research
  • ID: 5403292
The market for sleep apnea therapeutics and diagnostics in the Asia-Pacific is likely to progress with a CAGR of 8.50% in the forecast years from 2021 to 2028. China, Japan, India, Australia & New Zealand, ASEAN countries, South Korea, and Rest of APAC together constitute the market in this region.

The market in Singapore is emerging, owing to the rising healthcare expenditure and the integration of technology in its healthcare system. There is a designated sleep center in the country, named SingHealth Duke-NUS Sleep Centre, where the patients of the SingHealth institution are referred to seek sleep apnea diagnosis and treatment. The diagnosis is made using various techniques, like polysomnography testing and cardiorespiratory testing. The center also offers CPAP therapy and oral appliances therapy for sleep apnea treatment.

The market in South Korea is primarily driven by advancements in technology. For instance, various local companies, like NuEyne and Ybrain, are working on developing wearable devices to treat sleep apnea. Moreover, advancements in sleep diagnosis also include the utilization of piezoelectric sensors for pulse oximetry in sleep apnea patients. Further, COPD is one of the leading causes of death in the country, among people aged 80 years or older. This is a major health concern. With the expected increase in the population of the older adults, the demand for sleep apnea devices in South Korea is expected to increase, thus benefiting market growth.

COMPETITIVE OUTLOOK

The noteworthy players in the sleep apnea therapeutics and diagnostics market are BMC Medical Co Ltd, Medtronic PLC, Vyaire Medical Inc, Cadwell Industries Inc, Koninklijke Philips NV, Smiths Medical Inc, Somnomedics GmbH, and Teleflex Incorporated.

Table of Contents

1. Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market - Summary
2. Industry Outlook
2.1. Impact of Covid-19 on the Sleep Apnea Therapeutics and Diagnostics Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Bargaining Power of Buyers
2.3.2. Bargaining Power of Suppliers
2.3.3. Threat of Substitute Products
2.3.4. Threat of New Entrants
2.3.5. Competitive Rivalry
2.4. Legal, Policy & Regulatory Framework
2.5. Supply Chain Outlook
2.6. Market Attractiveness Index
2.7. Vendor Scorecard
2.8. Key Market Strategies
2.8.1. Acquisitions & Mergers
2.8.2. New Product Launches & Developments
2.8.3. Contracts and Partnerships
2.8.4. Business Expansions, Announcements & Divestitures
2.9. Market Drivers
2.9.1. Awareness Related to the Negative Impact of Untreated Sleep Apnea
2.9.2. Rise in Geriatric Population and Obesity Cases
2.9.3. Disturbed Sleep Due to Increased Use of Gadgets at Night-Time
2.10. Market Challenges
2.10.1. High Cost of Sleep Apnea Devices
2.10.2. Unfavorable Reimbursement Landscape
2.10.3. Lack of Patient Adherence to the Treatment Recommended
2.11. Market Opportunities
2.11.1. Increasing Usage of At-Home Monitoring Devices
2.11.2. Advancements in Technology
3. Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market - by Product Type
3.1. Therapeutics
3.1.1. Positive Airway Pressure (Pap) Devices
3.1.2. Oxygen Devices
3.1.3. Masks and Accessories
3.1.4. Oral Appliances
3.1.5. Adaptive Servo Ventilation (Asv) Devices
3.2. Diagnostics and Monitoring
3.2.1. Polysomnography Device (Psg)
3.2.2. Oximeter
3.2.3. Actigraphy Monitoring Device
3.2.4. Respiratory Polygraph
3.2.5. Sleep Apnea Screening Device
3.2.6. Other Diagnostics and Monitoring Devices
4. Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market - by Industry Verticals
4.1. Hospitals & Sleep Laboratories
4.2. Home Care Settings
5. Geographical Analysis - Asia-Pacific
5.1. Country Analysis
5.1.1. China
5.1.2. Japan
5.1.3. Australia & New Zealand
5.1.4. India
5.1.5. South Korea
5.1.6. Asean Countries
5.1.7. Rest of Asia-Pacific
6. Competitive Landscape
6.1. Bmc Medical Co Ltd
6.2. Braebon Medical Corporation
6.3. Cadwell Industries Inc
6.4. Devilbiss Healthcare LLC
6.5. Fisher & Paykel Healthcare Corporation Limited
6.6. GE Healthcare (General Electric Company)
6.7. Invacare Corporation
6.8. Itamar Medical Ltd
6.9. Koninklijke Philips Nv
6.10. Medtronic plc
6.11. Nihon Kohden Corporation
6.12. Signifier Medical Technologies Limited
6.13. Resmed Inc
6.14. Smiths Medical Inc
6.15. Somnomedics GmbH
6.16. Teleflex Incorporated
6.17. Vyaire Medical Inc
7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.1.2. Scope of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis
List of Tables
Table 1: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Acquisitions & Mergers
Table 4: New Product Launches & Developments
Table 5: Contracts and Partnerships
Table 6: Business Expansions, Announcements & Divestitures
Table 7: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Product Type, 2021-2028 (In $ Million)
Table 8: Asia-Pacific Therapeutics Market, by Type, 2021-2028 (In $ Million)
Table 9: Asia-Pacific Diagnostics and Monitoring Market, by Type, 2021-2028 (In $ Million)
Table 10: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 11: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Country, 2021-2028 (In $ Million)
List of Figures
Figure 1: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 2: Porter's Five Forces Model
Figure 3: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Product Type, 2020 & 2028 (In %)
Figure 4: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Therapeutics, 2021-2028 (In $ Million)
Figure 5: Asia-Pacific Sleep Apnea Therapeutics Market, by Positive Airway Pressure (Pap) Devices, 2021-2028 (In $ Million)
Figure 6: Asia-Pacific Sleep Apnea Therapeutics Market, by Oxygen Devices, 2021-2028 (In $ Million)
Figure 7: Asia-Pacific Sleep Apnea Therapeutics Market, by Masks and Accessories, 2021-2028 (In $ Million)
Figure 8: Asia-Pacific Sleep Apnea Therapeutics Market, by Oral Appliances, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Sleep Apnea Therapeutics Market, by Adaptive Servo Ventilation (Asv) Devices, 2021-2028 (In $ Million)
Figure 10: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Diagnostics and Monitoring, 2021-2028 (In $ Million)
Figure 11: Asia-Pacific Diagnostics and Monitoring Market, by Polysomnography Device (Psg), 2021-2028 (In $ Million)
Figure 12: Asia-Pacific Diagnostics and Monitoring Market, by Oximeter, 2021-2028 (In $ Million)
Figure 13: Asia-Pacific Diagnostics and Monitoring Market, by Actigraphy Monitoring Device, 2021-2028 (In $ Million)
Figure 14: Asia-Pacific Diagnostics and Monitoring Market, by Respiratory Polygraph, 2021-2028 (In $ Million)
Figure 15: Asia-Pacific Diagnostics and Monitoring Market, by Sleep Apnea Screening Device, 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Diagnostics and Monitoring Market, by Other Diagnostics and Monitoring Devices, 2021-2028 (In $ Million)
Figure 17: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Industry Verticals, 2020 & 2028 (In %)
Figure 18: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Hospitals & Sleep Laboratories, 2021-2028 (In $ Million)
Figure 19: Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market, by Home Care Settings, 2021-2028 (In $ Million)
Figure 20: China Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 21: Japan Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 22: Australia & New Zealand Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 23: India Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 24: South Korea Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 25: Asean Countries Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)
Figure 26: Rest of Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market 2021-2028 (In $ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • BMC Medical Co Ltd
  • Braebon Medical Corporation
  • Cadwell Industries Inc
  • Devilbiss Healthcare LLC
  • Fisher & Paykel Healthcare Corporation Limited
  • GE Healthcare (General Electric Company)
  • Invacare Corporation
  • Itamar Medical Ltd
  • Koninklijke Philips Nv
  • Medtronic plc
  • Nihon Kohden Corporation
  • Signifier Medical Technologies Limited
  • Resmed Inc
  • Smiths Medical Inc
  • Somnomedics GmbH
  • Teleflex Incorporated
  • Vyaire Medical Inc

Methodology

Loading
LOADING...